Media Gallery

eSVS Animation

This high quality animation that depicts the use of the eSVS Mesh device and its related components.

Note: This animation is intended for educational puposes only. For full eSVS Mesh precribing information please click on the Instructions For Use tab above.

Angio Videos

76 year old male with a 3.5mm eSVS® Mesh to RCA

Control vs. eSVS Mesh at 9 Months (Human)

Angiographic Results Venous Graft Treated with eSVS Mesh
Same Patient at 10 and 24 Months

Angiographic Results Venous Graft Treated with eSVS Mesh
Same Patient at 9 and 36 Months

6 Months CT Scan (Human)

Clinical eSVS Mesh Prep

Short video demonstrating saphenous vein preparation and deployment of the eSVS Mesh in a clinical case at the Universitatsspital Basel in Switzerland.

NOTE: The eSVS Mesh is NOT approved for sale in the USA.

"...advancing, refining, and improving cardiac surgery."

MKT-40040.001, Rev 01

Manny Villafaña

Co-Inventor of the first lithium pacemaker and Founder of CPI/Guidant Corporation
Co-Inventor of the St. Jude heart valve and Founder of St. Jude Medical Inc.
Co-Inventor the ATS heart valve and Founder of ATS Medical
Co-Founder of the Lillehei Surgical Society
Recipient "Living Legend of Medicine" Award
USA Master Entrepreneur Award
Minnesota Business Hall of Fame
NY Ellis Island Medal of Honor Recipient
Boys & Girls Club of America Hall of Fame
Kips Bay Medical is his seventh public company

MKT-40040.001, Rev 01

Previous Next

MKT-40040.001, Rev 01

Previous Next

MKT-40040.001, Rev 01

Previous Next

CONCEPT

The eSVS Mesh is designed to be placed over a saphenous vein graft so as to provide the physiological attributes of an artery by...

Providing radial constriction (approx. 25%), leading to arterial like flow velocities and shear stresses within the graft
Matching the typical compliance of an artery

MKT-40040.001, Rev 01

Previous Next

MKT-40040.001, Rev 01

Previous Next

6 Months Histology
Cross-Section Non-Mesh (Baboon) Vein

MKT-40040.001, Rev 01

Previous Next

MKT-40040.001, Rev 01

Previous Next

6 Months Histology Cross-Section
eSVS Mesh (Baboon) Supported Vein

MKT-40040.001, Rev 01

Previous Next

Control (lower) and eSVS Mesh (upper) Vein Implants (Sheep)

The eSVS Mesh was extensively tested in various animals models to demonstrate feasibility of the concept:

In a series of experimental models two vein bypasses were placed on the heart; one without support and one supported with the eSVS Mesh
Animals were then followed up with angiography at various time-points

MKT-40040.001, Rev 01

Previous Next

30 Days Sheep Angiogram

Untreated Venous Graft - "Control"

Venous Graft Treated with eSVS Mesh

MKT-40040.001, Rev 01

Previous Next

90 Days Sheep Angiogram

Untreated Venous Graft - "Control"

Venous Graft Treated with eSVS Mesh

MKT-40040.001, Rev 01

Previous Next

180 Days Sheep Gross Pathology/Histology

Venous graft treated with eSVS MESH

Untreated venous graft - "control"

MKT-40040.001, Rev 01

Previous Next

eSVS® Mesh External Saphenous Vein Support Study
Clinical Study Status July 21st, 2009

7 International Sites

Enrollment started August 2008

90 Patients

All implants successful

CENTER	SITE PI	NUMBER OF PATIENTS ENROLLED
National University Hospital, Singapore	Prof. Dr. Uwe Klima A/Prof. Dr. Theo Kofidis	21
University of Capetown, South Africa	A/Prof. Dr. Johan Brink	20
Schleswig-Holstein University Hospital, Kiel, Germany	Prof. Dr. Med. Jochen Cremer	25
Hospital Universitario 12 De Octubre, Madrid, Spain	Prof. Dr. Jose Maria Cortina	5
Hospital Regional De Sion, Sion, Switzerland	Dr. Frank Stumpe	9
Prince Charles Hospital, Brisbane, Australia	Dr. Trevor Fayers	2
Auckland City Hospital Auckland, New Zealand	Dr. Parma Nand	8

MKT-40040.001, Rev 01

Previous Next

MKT-40040.001, Rev 01

Previous Next

Angiographic Results
Control vs. eSVS Mesh at 9 Months (Human)

Untreated Venous Graft - "Control"

Venous Graft Treated with eSVS Mesh

MKT-40040.001, Rev 01

Previous Next

Angiographic Results
Control vs. eSVS Mesh at 9 Months (Human)

Untreated Venous Graft - "Control"

Venous Graft Treated with eSVS Mesh

MKT-40040.001, Rev 01

Previous Next

Angiographic Results Venous Graft Treated with eSVS Mesh
Same Patient at 10 and 24 Months

10 months

24 months

MKT-40040.001, Rev 01

Previous Next

Angiographic Results Venous Graft Treated with eSVS Mesh
Same Patient at 9 and 36 Months

9 months

36 months

MKT-40040.001, Rev 01

Previous Next

Angiographic Results Venous Graft Treated with eSVS Mesh
Same Patient at 9 and 36 Months

9 months

36 months

MKT-40040.001, Rev 01

Previous Next

6 Months CT Scan (Human)

MKT-40040.001, Rev 01

Previous Next

IVUS Interpretation eSVS Mesh and Control Vein
Segments 14 months Post Implant
(Single Frame at Mid Graft)

Control Vein LCX

eSVS Mesh Vein RCA

MKT-40040.001, Rev 01

Previous Next

CE Mark Approval May, 2010

MKT-40040.001, Rev 01

Previous Next

US Centers Indicating Interest in Participating
in Kips Bay Medical FDA Clinical Trials

Site	Location	Surgeons
Cleveland Clinic	Cleveland, Ohio	Dr. Joseph Sabik
Texas Heart Institute	Houston, Texas	Dr. Billy Cohn
Emory University	Atlanta, Georgia	Dr. John Puskas
Mayo Clinic	Rochester, Minnesota	Dr. Hartzell Schaff
University of California Medical Center	San Diego, California	Dr. Stuart Jamieson Dr. Michael Madani
Beth-Israel Medical Center	New York, New York	Dr. Robert Tranbaugh
Lenox Hill Hospital	New York, New York	Dr. Mani Subramanian Dr. Nirav Patel
Wisconsin Heart Hospital	Milwaukee, Wisconsin	Dr. Sam Balkhy

MKT-40040.001, Rev 01